Table 2.
Esophageal resections: comparison between 2019 and 2020
| 2019 | 2020 | P-value | |||
|---|---|---|---|---|---|
| Operations (n; %) | 60 | 100% | 65 | 100% | |
| Age [years](mean; SD) | 66.4 (±3.5) | 67.7 (±6.8) | 0.596# | ||
| Tumor location | |||||
| Gastro-esophageal junction carcinoma | 34 | 56.7% | 43 | 66.2% | 0.358¶ |
| Esophageal carcinoma | 26 | 43.3% | 22 | 33.8% | |
| Surgical approach | |||||
| Open (n; %) | 13 | 21.7% | 26 | 40.0% | 0.034¶ |
| Hybrid (n; %) | 18 | 30.0% | 13 | 20.0% | 0.219¶ |
| Laparoscopic/thoracoscopic (n; %) | 17 | 28.3% | 18 | 27.7% | 1¶ |
| Robot assisted (n; %) | 12 | 20.0% | 8 | 12.3% | 0.329¶ |
| Conversion (n; %) | 0/47 | 0% | 5/39 | 12.8% | 0.017¶ |
| Length of ICU stay [years](mean; SD) | 2.3 (±1.6) | 2.8 (±2.4) | 0.628# | ||
| Length of Hospital stay [years] (mean; SD) | 12.0 (±4.4) | 11.5 (±3.0) | 0.767# | ||
| Complications (n; %) | 31 | 51.6% | 34 | 52.2% | 1¶ |
| Dindo 1–2 | 15 | 25.0% | 19 | 29.2% | 0.689¶ |
| Dindo 3 | 11 | 18.3% | 6 | 9.2% | 0.192¶ |
| Dindo 4 | 5 | 8.3% | 8 | 12.3% | 0.564¶ |
| Dindo 5 | 0 | 0% | 1 | 1.5% | 1¶ |
| Anastomotic leak (n; %) | 4 | 6.7% | 9 | 13.8% | 0.246¶ |
# t-test
¶Fisher’s exact test